Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
genes decrease » teer decrease (Expand Search), sizes decrease (Expand Search), greatest decrease (Expand Search)
Showing 1,881 - 1,900 results of 21,342 for search '(( significant ((genes decrease) OR (greater decrease)) ) OR ( significant decrease decrease ))', query time: 0.63s Refine Results
  1. 1881
    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor grades. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 1882
    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes.

    Distribution of rs12529 (C15G) genotypes in patients with different tumor sizes. by Md. Akeruzzaman Shaon (21511929)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 1883
    Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period.

    Segmented regression analysis of time to intravenous antimicrobial administration (IVA) at intervention and control sites during the implementation period. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 1884
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Uganda during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 1885
    Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya.

    Kenya: Enrolment, time to IVA, mortality, admissions and readmissions at sites in Kenya. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 1886
    Uganda: enrolment, time to IVA, mortality, admissions and readmissions.

    Uganda: enrolment, time to IVA, mortality, admissions and readmissions. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 1887
    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods.

    Interrupted time series analysis showing time to intravenous antimicrobials (IVA) in minutes at intervention and control sites in Kenya during baseline and implementation periods. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 1888
    Bluetooth beacons with colour coded lanyards.

    Bluetooth beacons with colour coded lanyards. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 1889
    Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site.

    Flow diagram of the Smart Triage multisite interventional study in Uganda and Kenya indicating the progress through study phases at each site. by J Mark Ansermino (13958512)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 1890
    Gene expression changes in <i>lin-35(n745)</i> starved L1 animals.

    Gene expression changes in <i>lin-35(n745)</i> starved L1 animals. by Ashwin Seetharaman (615458)

    Published 2025
    Save to List
    Saved in:
  11. 1891
    Lymphocyte proliferation assay following combination therapy with NDV.

    Lymphocyte proliferation assay following combination therapy with NDV. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  12. 1892
    Tumor volume measurements.

    Tumor volume measurements. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  13. 1893
    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold change (2<sup>-ΔΔCt</sup>). miRNAs with a fold change greater than 1.3 in the vehicle group and at the 0.75–1.3 range (orange striped area) in the Bz and Bz + PTX therapy groups were considered to have a restored expression. They were selected for further analysis on IPA software. (A) The expression of miRNAs was altered in the infected group and an expression was restored after Bz therapy. (B) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (C) Diseases and disorders pathway analysis. (D) The expression of miRNAs was altered in the infected group and restored upon Bz + PTX therapy. (E) Top canonical activated pathways in the infected group with a restored expression upon Bz therapy. (F) Diseases and disorders pathway analysis. Significant intervals

    Characterization of miRNA expression profiles and their potential targets upon Bz and Bz + PTX therapy in chronically infected mice. Relative expression was expressed as fold chang... by Glaucia Vilar-Pereira (686134)

    Published 2025
    Save to List
    Saved in:
  14. 1894
    IL-10 levels in tumor lysates post-treatment.

    IL-10 levels in tumor lysates post-treatment. by Hedieh Zargaran (21410233)

    Published 2025
    Save to List
    Saved in:
  15. 1895
    Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10<sup>7</sup> CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated withA. TYL (3 times, q7D), B. LMC (3 times, q7D), C. sham (3 times, q7D), D. OTC (3 times, q4D), E. OTC (1 time) and F. sham (3 times, q4D. Red-dotted line represents calculated inoculation dose (CFU/bee) administered on day 1. *, represents significant differences from D3 bacterial load, with P < 0.05.

    Median ± IQR <i>M. plutonius</i> bacterial load (CFU/bee) of newly emerged summer worker bees inoculated with 1 × 10<sup>7</sup> CFU/bee <i>M. plutonius</i> 2019BC1 and/or treated... by Midhun Sebastian Jose (19336846)

    Published 2025
    Save to List
    Saved in:
  16. 1896
    The eight growing conditions generated by combining different heat shock stimuli and PGA1 addition.

    The eight growing conditions generated by combining different heat shock stimuli and PGA1 addition. by Enrique Paz-Cortés (20988196)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 1897
    Specific yields and the BV-genomes copy number-to-PFU ratio (BV-genomes PFU<sup>-1</sup>) at different times post-infection.

    Specific yields and the BV-genomes copy number-to-PFU ratio (BV-genomes PFU<sup>-1</sup>) at different times post-infection. by Enrique Paz-Cortés (20988196)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 1898
    The four phases of AcMNPV infection cycle and the design of dual reporter baculovirus (DRBac).

    The four phases of AcMNPV infection cycle and the design of dual reporter baculovirus (DRBac). by Enrique Paz-Cortés (20988196)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 1899
    Heat shock induced alterations in the production of viral progeny and baculovirus genomes.

    Heat shock induced alterations in the production of viral progeny and baculovirus genomes. by Enrique Paz-Cortés (20988196)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 1900
    Dynamics of EGFP and mRFP fluorescence in infected cells under different heat shock conditions.

    Dynamics of EGFP and mRFP fluorescence in infected cells under different heat shock conditions. by Enrique Paz-Cortés (20988196)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: